Kortex Ventures

Kortex Ventures concentrates on early-stage Life Science and HealthTech startups that leverage applied artificial intelligence and data infrastructure to address healthcare gaps in Latin America. The firm targets technical founders building solutions that must operate within Brazil's ANVISA-regulated medical environment.

Kortex occupies a narrow specialist lane that combines data-science underwriting with deep healthcare regulatory knowledge — specifically the navigational requirements of Brazil's unified health system. Most local VC peers treat HealthTech as one allocation among many, while generalist data funds lack the clinical deployment fluency Kortex mandates.

Kortex's posture toward leading rounds is not publicly documented. As a specialist early-stage firm, its typical behavior in Latin American HealthTech deals likely involves serving as a domain-expert co-investor or lead for pre-seed and seed rounds where regulatory due diligence is the binding constraint.

Kortex is headquartered in São Paulo and concentrates on Brazil as its primary market, with potential expansion into Spanish-speaking Latin American healthcare markets — notably those with fragmented health infrastructure similar to Brazil's.

Public records do not specify a follow-on reserve policy, though early-stage specialist firms of Kortex's profile typically maintain reserves for their highest-conviction portfolio companies through subsequent funding rounds.